1. Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study. Issue 4 (3rd August 2021) Authors: Nasonov, Evgeniy; Fatenejad, Saeed; Feist, Eugen; Ivanova, Mariana; Korneva, Elena; Krechikova, Diana G; Maslyanskiy, Aleksey L; Samsonov, Mikhail; Stoilov, Rumen; Zonova, Elena V; Genovese, Mark Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 4(2022) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study. Issue 12 (15th September 2022) Authors: Feist, Eugen; Fatenejad, Saeed; Grishin, Sergey; Korneva, Elena; Luggen, Michael E; Nasonov, Evgeniy; Samsonov, Mikhail; Smolen, Josef S; Fleischmann, Roy M Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 12(2022) Page Start: 1661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P131 Efficacy and safety of olokizumab in a phase III trial of patients with moderately to severely active RA inadequately controlled by methotrexate: placebo and active controlled study. (26th April 2021) Authors: Feist, Eugen; Chohan, Saima; Fatenejad, Saeed; Grishin, Sergey; Korneva, Elena; Nasonov, Evgeniy L; Rowińska-Osuch, Anna; Samsonov, Mikhail Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P136 Efficacy and safety of olokizumab in a phase III trial in patients with moderately to severely active RA inadequately controlled by TNF-α inhibitor therapy. (26th April 2021) Authors: Feist, Eugen; Fatenejad, Saeed; Grishin, Sergey; Korneva, Elena; Luggen, Michael; Nasonov, Evgeniy; Samsonov, Mikhail Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PREVENTIVE TUFTSIN-PHOSPHORYLCHOLINE ACTION ON THE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN THE MICE DEVELOPMENT IN MICE C57BL/6. Issue 3 (September 2018) Authors: Novikova, Natalia; Diatlova, Anastasiia; Derevtsova, Kristina; Korneva, Elena; Blank, Miri; Shoenfeld, Yehuda Journal: Pathophysiology Issue: Volume 25:Issue 3(2018) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗